You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company has taken an exclusive license to the Casɸ proteins and is working to characterize their capabilities to determine how they can best be used.
The seven technologies feature different methods, including CRISPR and microfluidics, and can be performed in many settings and with a variety of sample types.
Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
The research network said in a statement that precision breeding techniques are needed to achieve the UN's Sustainable Development Goals.
Grist reports that a University of California, Davis, team has edited the genome of a calf so that he'll be more likely to produce male offspring.
Tropic Bio will use its GEiGS (Gene Editing induced Gene Silencing) platform to develop desirable agricultural traits in BASF's strategic crop varieties.
The technology could be developed into therapies for diseases caused by DNA transversion point mutations, and used to conduct molecular research on such conditions.
In Science this week: model to predict coral bleaching, and more.
The CasΦ nuclease, which was first discovered in February, is one of the most compact CRISPR proteins ever found, and is active in both human and plant cells.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.